Amylyx Pharmaceuticals, Inc. AMLX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s common stock?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported common stock of $11K in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s common stock increased by 22.2% year-over-year, from $9K to $11K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s common stock?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s common stock has grown at a 82.1% compound annual growth rate (CAGR), from $1K to $11K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).